About Index Trending news
Analyze
Pricing
Tarveda Therapeutics

Tarveda Therapeutics

Work at Tarveda Therapeutics? Add yourself to this profile

Tarveda Therapeutics

Blend discovers and develops integrative nanomedicines to target distinctdisease pathways safely and efficiently.

Elsewhere

Contributors to this profile

Alexa global traffic share

02 Feb 2017
$30,000,000
Venture capital (Series D)

Tarveda Therapeutics Raises $30M in Series D Financing

FinSMEs
+1
27 Jan 2016
$38,000,000
Venture capital (Series C)
Added by

Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug

Xconomy
+1